Results

Mitsubishi Tanabe Pharma Corporation

10/09/2019 | Press release | Distributed by Public on 10/08/2019 20:25

Mitsubishi Tanabe Pharma enters into a licensing agreement with Viela Bio for inebilizumab, a treatment agent for neuromyelitis optica spectrum disorder, in Japan and other[...]